Mason Street Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Mason Street Advisors's AMPH Position: Q1 2021 in Review
Mason Street Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2021, closing a stake of 13,640 shares — an estimated $274K sold.
Mason Street Advisors first reported a position in AMPH in Q3 2016 and held it in 18 quarters. The position peaked at $284K in Q2 2020. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2021.
- Mason Street Advisors reported no remaining Amphastar Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 13,640 Amphastar Pharmaceuticals shares in Q1 2021, an estimated $274K.
- Mason Street Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 18 quarters.
- Mason Street Advisors's Amphastar Pharmaceuticals position peaked at $284K in Q2 2020.
- 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.